Kim Tsuchimoto

Kim Tsuchimoto

Director/Miembro de la Junta en MONOPAR THERAPEUTICS INC. .

Fortuna: 747 049 $ al 31/05/2026

63 años
Health Technology
Technology Services
Consumer Durables

Perfil

Ms. Kim R.
Tsuchimoto
, CPA, is an Independent Director at Thiogenesis Therapeutics Corp.
She is on the Board of Directors at Thiogenesis Therapeutics Corp., Monopar Therapeutics, Inc. and Thiogenesis Therapeutics, Inc. /New/.
Ms. Tsuchimoto was previously employed as a Chief Financial Officer by Mercaptor Discoveries, Inc., a Treasurer, VP-International Finance & Tax by Horizon Pharmaceutical LLC, a VP-Financial Planning & Analysis, Internal Control by Raptor Pharmaceuticals Corp., a Chief Financial Officer, Secretary & Treasurer by Raptor Pharmaceutical, Inc., a Controller by International Microcomputer Software, Inc., a Controller & Assistant Vice President by SpatiaLight, Inc., a Vice President-Treasurer & Controller by BioMarin Pharmaceutical, Inc., and a Treasurer, Vice President & Controller by Glyko, Inc. She received her undergraduate degree from San Francisco State University.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
31/03/2026 11.486 ( 0,17 % ) 747 049 $ 31/05/2026

Cargos activos de Kim Tsuchimoto

EmpresasCargoInicio
MONOPAR THERAPEUTICS INC. Director/Miembro de la Junta 01/03/2023
THIOGENESIS THERAPEUTICS, CORP. Director/Miembro de la Junta 31/03/2022

Antiguos cargos conocidos de Kim Tsuchimoto.

EmpresasCargoFin
Fundador 01/08/2019
Director Financiero/CFO 01/05/2015
Comptroller/Controller/Auditor 01/03/2006
SPATIALIGHT, INC. Comptroller/Controller/Auditor 23/08/2005
BIOMARIN PHARMACEUTICAL INC. Comptroller/Controller/Auditor 01/06/2005
Ver el detalle de la experiencia de Kim Tsuchimoto.

Formación de Kim Tsuchimoto.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

43

Relaciones de 1er grado

11

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas11

Technology Services

Consumer Durables

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Finance

-40%: Ampliación de plazo extraordinaria
d
:
:
APROVECHAR LA PROMOCIÓN